Skip to main content

SCD DRC A Phase 3 Randomized, Double-Masked, Parallel Group, Multicenter Study to Compare the Efficacy, Safety, Tolerability, Pharmacokinetics and Immunogenicity between SCD411 and Eylea® in Subjects with Neovascular Age-related Macular Degeneration

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Sam Chun Dang Pharm. Co., Ltd

Start Date

September 1, 2019

End Date

December 31, 2022
 

Administered By

Ophthalmology

Awarded By

Sam Chun Dang Pharm. Co., Ltd

Start Date

September 1, 2019

End Date

December 31, 2022